Keywords: Sanofi-Aventis, Second-quarter 2010 fiancial results, Genzyme M&A rumors, Lovenox, Law suti, FDA

Sanofi-Aventis 2nd-qtr 2010 earnings up 8%, but firm still mute on Genzyme acquisition; sues over Lovenox

Article | 29 July 2010

Print This

Sanofi Aventis posted a strong set of second-quarter 2010 results this morning, but the company’s chief executive Chris Viehbacher, unveiling ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in